Hims & Hers Pullback Could Create a Better Entry Into GLP-1 Demand
The healthcare sector is one of the best-performing sectors in the S&P 500 over the past month, with a gain of around 6%. But while that rebound has been led by a handful of mega-cap Big Pharma companies, it has also been reflected in the performances of smaller firms. One of those is mid-cap Hims ...











